Pumis Biotech announced the appointment of Dr. Bao Jun as Chief Commercial Officer (CBO), responsible for the group’s global business development and cooperation planning, reporting directly to Chairman and CEO Mr. Liu Xiaolin. Dr. Jun Bao has over 20 years of extensive experience in drug discovery, technology transfer, licensing and business development, venture capital, entrepreneurship and corporate finance. He has successively served as Deputy Director of Business Development of Seattle ICOS Company, Senior Manager of Business Development of Oncology Biomedical Company Cell Therapeutics Company, Director of Corporate Development and Financing Planning of Onyx, a famous cancer pharmaceutical company in the United States, Global Business Development Director and China Region of multinational pharmaceutical company GlaxoSmithKline Director, Senior Vice President and Chief Commercial Officer of Shenaoji Pharmaceutical Company. Dr. Bao Jun is a Ph.D. in Neurobiology from the University of Kansas, a post-doctoral fellow at Johns Hopkins University, and an MBA in Finance from the University of Chicago. Before joining Pumis, Dr. Bao Jun served as General Manager and Chief Executive Officer (CEO) of Yingpai Pharmaceuticals. At the same time, Dr. Bao Jun is also the chairman of Tongxieyi BD Club.
This article is reproduced from: https://business.sohu.com/a/591878974_121124543
This site is for inclusion only, and the copyright belongs to the original author.